No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr6:27215600-27218800 |
Bivalent/Poised TSS |
Fetal Thymus |
thymus
|
2 |
chr6:27216000-27218200 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
3 |
chr6:27217600-27218200 |
Enhancers |
K562 |
blood
|
4 |
chr6:27217800-27218400 |
Flanking Bivalent TSS/Enh |
iPS-20b Cell Line |
embryonic stem cell
|
5 |
chr6:27217800-27218600 |
Bivalent/Poised TSS |
HUES64 Cell Line |
embryonic stem cell
|
6 |
chr6:27217800-27220200 |
Active TSS |
H1 Cell Line |
embryonic stem cell
|
7 |
chr6:27218000-27218200 |
Bivalent/Poised TSS |
HUES48 Cell Line |
embryonic stem cell
|
8 |
chr6:27218000-27218200 |
Bivalent/Poised TSS |
iPS-18 Cell Line |
embryonic stem cell
|
9 |
chr6:27218000-27218200 |
Enhancers |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
10 |
chr6:27218000-27218400 |
Bivalent/Poised TSS |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
11 |
chr6:27218000-27218400 |
Flanking Bivalent TSS/Enh |
HUES6 Cell Line |
embryonic stem cell
|
12 |
chr6:27218000-27218400 |
Flanking Bivalent TSS/Enh |
iPS-15b Cell Line |
embryonic stem cell
|
13 |
chr6:27218000-27218400 |
Flanking Active TSS |
ES-UCSF4 Cell Line |
embryonic stem cell
|
14 |
chr6:27218000-27218400 |
Enhancers |
HMEC |
breast
|
15 |
chr6:27218000-27218600 |
Flanking Active TSS |
GM12878-XiMat |
blood
|
16 |
chr6:27218000-27218800 |
Bivalent/Poised TSS |
ES-I3 Cell Line |
embryonic stem cell
|
17 |
chr6:27218000-27220000 |
Active TSS |
Breast Myoepithelial Primary Cells |
Breast
|
18 |
chr6:27218000-27220200 |
Active TSS |
H9 Cell Line |
embryonic stem cell
|
19 |
chr6:27218000-27220200 |
Bivalent/Poised TSS |
Primary T cells from cord blood |
blood
|
20 |
chr6:27218200-27218400 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
21 |
chr6:27218200-27218400 |
Enhancers |
H1 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
22 |
chr6:27218200-27218400 |
Flanking Active TSS |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
23 |
chr6:27218200-27218400 |
Bivalent Enhancer |
Primary T cells fromperipheralblood |
blood
|
24 |
chr6:27218200-27218400 |
Bivalent/Poised TSS |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
25 |
chr6:27218200-27218400 |
Active TSS |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
26 |
chr6:27218200-27218400 |
Bivalent/Poised TSS |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
27 |
chr6:27218200-27218400 |
Bivalent/Poised TSS |
Brain Substantia Nigra |
brain
|
28 |
chr6:27218200-27218400 |
Bivalent Enhancer |
Fetal Intestine Large |
intestine
|
29 |
chr6:27218200-27218400 |
Bivalent Enhancer |
Placenta |
Placenta
|
30 |
chr6:27218200-27218400 |
Flanking Active TSS |
Pancreas |
Pancrea
|
31 |
chr6:27218200-27218400 |
Bivalent Enhancer |
Stomach Mucosa |
stomach
|
32 |
chr6:27218200-27218400 |
Enhancers |
NHEK |
skin
|
33 |
chr6:27218200-27218600 |
Bivalent Enhancer |
Primary B cells from peripheral blood |
blood
|
34 |
chr6:27218200-27218600 |
Bivalent Enhancer |
Primary T helper cells fromperipheralblood |
blood
|
35 |
chr6:27218200-27218600 |
Bivalent Enhancer |
Primary Natural Killer cells fromperipheralblood |
blood
|
36 |
chr6:27218200-27218600 |
Bivalent/Poised TSS |
Rectal Smooth Muscle |
rectum
|
37 |
chr6:27218200-27218600 |
Flanking Active TSS |
K562 |
blood
|
38 |
chr6:27218200-27218800 |
Bivalent/Poised TSS |
Rectal Mucosa Donor 29 |
rectum
|
39 |
chr6:27218200-27219800 |
Bivalent/Poised TSS |
Aorta |
Aorta
|
40 |
chr6:27218200-27220000 |
Active TSS |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
41 |
chr6:27218200-27220000 |
Active TSS |
A549 |
lung
|
42 |
chr6:27218200-27220200 |
Bivalent/Poised TSS |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
43 |
chr6:27218200-27220200 |
Active TSS |
iPS-18 Cell Line |
embryonic stem cell
|
44 |
chr6:27218200-27220200 |
Active TSS |
Duodenum Mucosa |
Duodenum
|
45 |
chr6:27218200-27220400 |
Active TSS |
HUES48 Cell Line |
embryonic stem cell
|